Characterization of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli by DNA sequence analysis and MAMA PCR

FEMS Microbiology Letters

Volumn 190, Issue 1, 2000, Pages 1-7

  Zirnstein, Gerald ^a   Helsel, Leta ^a   Li, Yu ^a   Swaminathan, Bala ^a   Besser, John ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Campylobacter coli; Ciprofloxacin resistance; GyrA mutation; Mismatch polymerase chain reaction

Indexed keywords

BACTERIAL DNA; CIPROFLOXACIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BASE MISPAIRING; CAMPYLOBACTER COLI; CONTROLLED STUDY; GENE MUTATION; GENETIC RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STRAIN DIFFERENCE;

ANTI-INFECTIVE AGENTS; BASE SEQUENCE; CAMPYLOBACTER COLI; CAMPYLOBACTER INFECTIONS; CIPROFLOXACIN; DNA GYRASE; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE, MICROBIAL; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; NALIDIXIC ACID; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 0034283733     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(00)00306-2     Document Type: Article

References (27)

1. Nachamkin, I. (1993) Campylobacter infections. Curr. Opin. Infect. Dis. 6, 72-76.
2. Piddock, L.J.V. (1995) Review: quinolone resistance and Campylobacter spp.. J. Antimicrob. Chemother. 36, 891-898.
3. Taylor, D.N., Sanchez, J.L., Candler, W., Thornton, S., McQueen, C. and Escheverria, P. (1991) Treatment of travellers diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. Ann. Intern. Med. 114, 731-734.
4. Gilbert, D.N., Moellering, Jr., R.C. and Sande, M.A. (1999) In: The Sandford Guide to Antimicrobial Therapy, p. 12 and p. 48. Antimicrobial Therapy, Hyde Park, VT.
5. Abramowicz, M. (Ed.) (1998) In: The Medical Letter Handbook of Antimicrobial Therapy, p. 43. The Medical Letter, New Rochelle, NY.
6. Koenraad, P.M.F.J., Jacobs-Reitsma, W.F., Van der Laan, T., Beumer, R.R. and Rombouts, F.M. (1995) Antibiotic susceptibility of Campylobacter isolates from sewage and poultry abattoir drain water. Epidemiol. Infect. 115, 475-483.
7. Sjögren, E., Lindblom, G.B. and Kaijser, B. (1997) Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients. J. Antimicrob. Chemother. 40, 257-261.
8. Kuschner, R.A., Trofa, A.F., Thomas, R.J., Hoge, C.W., Pitarangsi, C. and Amato, C. et al. (1995) Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin. Infect. Dis. 21, 536-541.
9. Gaunt, P.N. and Piddock, L.J.V. (1996) Ciprofloxacin resistant Campylobacter spp. In humans: an epidemiological and laboratory study. J. Antimicrob. Chemother. 37, 747-757.
10. Zirnstein, G.W., Li, Y., Swaminathan, B. and Angulo, F. (1999) Ciprofloxacin resistance in Campylobacter jejuni isolates: detection of gyrA resistance mutations by MAMA PCR and DNA sequence analysis. J. Clin. Microbiol. 37, 3276-3280.
11. Smith, K., Besser, J.M., Hedberg, C.W., Leano, F.T., Bender, J.B. and Wicklund, J.H. et al. (1999) Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team (see comments). N. Engl. J. Med. 340, 1525-1532.
12. Establishment of a National Surveillance Program for Antimicrobial Resistance in Salmonella (1996) Centers for Disease Control and Prevention, Morbidity and Mortality Weekly Report, February 9, 45(05), pp. 110-111.
13. Adler Mosca, H., Lüthy-Hottenstein, J., Martinetti, G., Burnens, A.P. and Alwegg, M. (1991) Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin. Eur. J. Clin. Microbiol. Infect. Dis. 10, 953-957.
14. Segreti, J., Gootz, T.D., Goodman, L.J., Parkhurst, G.W., Quinn, J.P., Martin, B.A. and Trenholme, G.M. (1992) High-level quinolone resistance in clinical isolates of Campylobacter jejuni. J. Infect. Dis. 165, 667-670.
15. Maxwell, A. (1992) The molecular basis of quinolone action. J. Antimicrob. Chemother. 30, 409-414.
16. Sugino, A., Peebles, C.L., Kreuzer, K.N. and Cozzarelli, N.R. (1977) Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc. Natl. Acad. Sci. USA 74, 4767-4771.
17. Taylor, D.E. and Chau, A. (1997) Cloning and nucleotide sequence of the gyrA gene from Campylobacter fetus subsp. fetus ATCC 27374 and characterization of ciprofloxacin-resistant laboratory and clinical isolates. Antimicrob. Agents Chemother. 28, 708-710.
18. Wang, Y., Huang, W.M. and Taylor, D.E. (1993) Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations. Antimicrob. Agents Chemother. 37, 457-463.
19. Yoshida, H., Bogaki, M., Nakamura, M. and Nakamura, S. (1990) Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34, 1271-1272.
20. Drlica, K. and Zhao, X. (1997) DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61, 377-392.
21. Hallett, P. and Maxwell, A. (1991) Novel quinolone resistance mutations of the E. coli DNA gyrase A protein; enzymatic analysis of the mutant proteins. Antimicrob. Agents Chemother. 35, 335-340.
22. Charvalos, E., Peteinaki, E., Spyridaki, I., Manetas, S. and Tselentis, Y. (1996) Detection of ciprofloxacin resistance mutations in Campylobacter jejuni gyrA by nonradioisotopic single-strand conformation polymorphism and direct DNA sequencing. J. Clin. Lab. Anal. 10, 129-133.
23. Linton, D., Owen, R.J. and Stanley, J. (1996) Rapid identification by PCR of the genus Campylobacter and of five Campylobacter species enteropathogenic for man and animals. Res. Microbiol. 147, 707-718.
24. Gonzalez, I.., Grant, K.A., Richardson, P.T., Park, S.F. and Collins, M.D. (1997) Specific identification of the enteropathogens Campylobacter jejuni and Campylobacter coli by using a PCR test based on the ceuE gene encoding a putative virulence determinant. J. Clin. Microbiol. 35, 759-763.
25. National Committee for Clinical Laboratory Standards (1997) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that grow Aerobically, 4th edn. Approved Standard M7-A4, 4th edn., National Committee for Clinical Laboratory Standards, Wayne, Pennsylvania.
26. National Committee for Clinical Laboratory Standards (1998) Performance Standards for Antimicrobial Susceptibility Testing; 8th Informational Suppl.. NCCLS document M100-S8. National Committee for Clinical Laboratory Standards, Wayne, PA.
27. Cha, R.S., Zarbl, H., Keohavong, P. and Thilly, W.G. (1992) Mismatch amplification mutation assay (MAMA): application to the c-H-ras gene. In: PCR Methods and Applications, pp. 14-20. Cold Spring Harbor Laboratory Press, Plainview, NY.